Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

NCT04173832 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

L-DOPA-Induced Dyskinesia

Interventions

DRUG: Tianqi Pingchan Granule Combined With Amantadine
DRUG: Placebo Combined With Amantadine

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]